Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Daljit Singh Aurora

See Remarks at Neumora Therapeutics, Inc. (NMRA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.0M

Reported trades

Filed Stock Type Shares Price Value Since
Aug 21SEC NMRANeumora Therapeutics, Inc. Sell 67,74148,750 held (−58%) $1.51 $102K -68.5%
Aug 21SEC NMRANeumora Therapeutics, Inc. Sell 66,711 $1.51 $101K -68.5%
Aug 21SEC NMRANeumora Therapeutics, Inc. Sell 20,55348,750 held (−30%) $1.59 $33K -70.1%
Aug 21SEC NMRANeumora Therapeutics, Inc. Sell 21,055 $1.60 $34K -70.2%
Aug 19SEC NMRANeumora Therapeutics, Inc. Sell 57,67082,770 held (−41%) $1.51 $87K -68.5%
Aug 19SEC NMRANeumora Therapeutics, Inc. Sell 34,02048,750 held (−41%) $1.49 $51K -68.1%
Aug 19SEC NMRANeumora Therapeutics, Inc. Sell 55,016 $1.50 $83K -68.3%
Aug 19SEC NMRANeumora Therapeutics, Inc. Sell 34,16248,750 held (−41%) $1.58 $54K -69.9%
Aug 19SEC NMRANeumora Therapeutics, Inc. Sell 34,987 $1.59 $56K -70.1%
Aug 19SEC NMRANeumora Therapeutics, Inc. Sell 31,00048,750 held (−39%) $1.65 $51K -71.2%
Aug 19SEC NMRANeumora Therapeutics, Inc. Sell 30,918 $1.65 $51K -71.2%
Feb 19SEC NMRANeumora Therapeutics, Inc. Sell 6,16582,770 held (−7%) $3.56 $22K -86.6%
Nov 13SEC NMRANeumora Therapeutics, Inc. Sell Plan 114,703 $2.68 $307K -82.2%
  • Sell

    See Remarks Daljit Singh Aurora sold $102K of NMRA at $1.51 — cuts the stake by 58%.

  • Sell

    See Remarks Daljit Singh Aurora sold $33K of NMRA at $1.59 — cuts the stake by 30%.

  • Sell

    See Remarks Daljit Singh Aurora sold $87K of NMRA at $1.51 — cuts the stake by 41%.

  • Sell

    See Remarks Daljit Singh Aurora sold $51K of NMRA at $1.49 — cuts the stake by 41%.

  • Sell

    See Remarks Daljit Singh Aurora sold $54K of NMRA at $1.58 — cuts the stake by 41%.

  • Sell

    See Remarks Daljit Singh Aurora sold $51K of NMRA at $1.65 — cuts the stake by 39%.